Join Joseph Coniglio, Director of Antitrust and Innovation at The Schumpeter Project, ITIF, as he inaugurates Creative Discussion: An Antitrust Podcast. In this first episode, Coniglio engages in an in-depth discussion with Herb Hovenkamp, James G. Dinan Professor at the University of Pennsylvania Law School. Dubbed the 'Dean of Antitrust' by the New York Times, Hovenkamp shares his career journey, insights on his influential Areeda-Hovenkamp treatise, and perspectives on significant antitrust issues.

Regulating how AI is used—not how it's built—is the only way to protect innovation and give small startups a fair shot. Rob and Jackie sit down with Matt Perault, Head of Artificial Intelligence Policy at Andreessen Horowitz, to discuss the significant burden regulatory frameworks can place on smaller tech companies and the critical role of government in AI regulation.

• Ezra Klein and Derek Thompson, Abundance, (Simon and Schuster, March 2025).
• Robert D. Atkinson and Meghan Ostertag, “Congress Should Fully Fund NSF’s TIP Directorate to Make America More Competitive Versus China,” (ITIF, June 2025).
• Robert D. Atkinson, “2025 Bromley Memorial Lecture: US Science Policy at a Crossroads,” (ITIF, March 2025).

• Matt Perault, “A Policy Blueprint for US Investment in AI Talent and Infrastructure,” (Andreessen Horowitz, Marc 2025).

Continued innovation and investment is vital to maintaining the U.S.'s leadership in the biopharma sector. Rob and Jackie sit down with Andrew Geall, Chief Development Officer at Replicate Bioscience, and Deborah Barbara, strategic advisor to Primrose Bio, to discuss the development and potential of mRNA as the fourth pillar of pharmaceutical innovation.

• Sandra Barbosu, “Harnessing AI to Accelerate Innovation in the Biopharmaceutical Industry,” (ITIF, November 2024)
• Richard Fleischer, dir. Fantastic Voyage, (20th Century-Fox, 1966).

• Stephen Ezell and Meghan Ostertag, “The Bayh-Dole Act’s Role in Stimulating University-Led Regional Economic Growth,” (ITIF, June 2025)